Greg Shaw

Professor Greg Shaw is a prominent consultant urologist at University College London Hospitals NHS Foundation Trust and the lead investigator of a groundbreaking trial on a new prostate cancer surgery method known as NeuroSafe. His research focuses on improving surgical outcomes for men with prostate cancer, specifically in preserving erectile function post-surgery. Shaw's work highlights the importance of nerve-sparing techniques in prostate cancer surgeries, aiming to enhance the quality of life for patients.